Summary
Depressed cellular immune function has been demonstrated in patients with a variety of lymphoreticular and nonlymphoreticular neoplasms, including patients harboring brain tumors. In the present study, peripheral T lymphocytes from more than fifty percent of patients with central nervous system tumors, both primary and metastatic, exhibited depressed incorporation of 3H-thymidine in response to phytohemagglutinin (PHA) when tests were performed in the absence of autologous serum. Increased numbers of monocytes were present within mononuclear cell suspensions from brain tumor patients, and most of the cell populations containing elevated monocytes also exhibited depressed responses to PHA. A role for monocytes as suppressor cells was suggested by the finding that partial reconstitution of T cell function could frequently be effected by adherent cell depletion. However, total reversal of the defect was rare and there was no relationship between monocytes and T cell dysfunction in some patients. The results suggest that while monocytes may be involved in the immune depression seen in some patients with a brain tumor, the complete explanation is as yet unknown.
Similar content being viewed by others
References
Brooks WA, Netsky MG, Normansell DE, Horwitz DA: Depressed cell-mediated immunity in patients with primary intracranial tumors. J Exp Med 136:1631–1637, 1972.
Young HF, Sakalas R, Kaplan AM: Inhibition of cell-mediated immunity in patients with brain tumors. Surg Neurol 5:19–23, 1976.
Mahaley MS, Brooks WH, Rozmann TL, Bigner DD, Dudka L, Richardson S: Immunobiology of primary intracranial tumors: Studies of the cellular and humoral general immune competence of brain tumor patients. J Neurosurg 46:467–476, 1977.
Hellstrom KB, Hellstrom I, Nepom JT: Specific blocking factors, are they important? Biochim Biophys Acta 473:121–148, 1977.
Goodwin JS, Messner RD, Bankhurst AD, Peake GT, Saiki JH, Williams RC: Prostaglandin producing suppressor cells in Hodgkins disease. N Engl J Med 297:963–968, 1977.
Hillinger SM, Hertig GD: Impaired cell-mediated immunity in Hodgkins disease mediated by suppressor lymphocytes and monocytes. J Clin Invest 60:1620–1627, 1978.
Jerrels TR, Dean JH, Richardson GL, McCoy JL, Herberman RB: Role of suppressor cells in depression of in vitro lymphoproliferative responses of lung cancer and breast cancer patients. J Natl Cancer Inst 61:1001–1009, 1978.
Quan PC, Burtin P: Demonstration of nonspecific suppressor cells in the peripheral lymphocytes of cancer patients. Cancer Res 38:288–296, 1978.
Schechter GP, Soehnlen F: Monocyte-mediated inhibition of lymphocyte blastogenesis in Hodgkin's disease. Blood 52:261–291, 1968.
Twomey JJ, Laughter AH, Farrow S, Douglas CC: Hodgkins disease: An immunodepletive and immunosuppressive disorder. J Clin Invest 56:467–475, 1975.
Zembala M, Mytar B, Popiela T, Asherson G: Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells. Int J Cancer 19:605–613, 1977.
Ellner TJ, Spagnuolo PJ: Suppression of antigen and mitogen induced human T lymphocyte DNA synthesis by bacterial lipopolysaccharide: Mediation by monocyte activation and production of prostaglandins. J Immunol 123:2689–2685, 1979.
Novogrodsky A, Rubin AL, Stenzel KH: Selective suppression by adherent cells, prostaglandin and cyclic AMP analogues of blastogenesis induced by different mitogens. J Immunol 122:1–7, 1979.
Dubey D, Stux S, Yunis E: Suppression of the cytotoxic responded (CML) in man by precultured cells: Association with a monocyte/ macrophage cell fraction. Transplant Proc 11:1833–1837, 1979.
Wood GW, Neff JB, Stephens R: Relationship between monocytosis and T lymphocyte function in human cancer. J Natl Cancer Inst 63:587–592, 1979.
Grossi CE, Webb SR, Zicca A, Lydyard PM, Moretta L, Mingari MD, Cooper MD: Morphological and histochemical analyses of two human T cell subpopulations bearing receptors for IgM or IgG. J Exp Med 147:1405–1417, 1978.
Wood GW, Neff JR: A reevaluation of B-lymphocyte levels in peripheral blood from cancer patients. J Natl Cancer Inst 61:715–718, 1978.
Fauci AS, Dole DC: The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest 53:240–246, 1974.
Oppenheim J, Leventhal B, Hersh E: The transformation of column-purified lymphocytes with nonspecific and specific antigenic stimuli. J Immunol 101: 262–270, 1968.
Brooks WH, Rozman TL, Mahaley MS, Woosley RE: Immunobiology of primary intracranail tumors: Analysis of lymphocyte subpopulations in patients with primary brain tumors. Clin Exp Immunol 29:61–66, 1967.
Wood GW, Morantz RA: In vitro reversal of depressed T lymphocyte function in brain tumor patients peripheral blood. J Natl Cancer Inst 68:27–33, 1982.
Braun DP, Penn RD, Harris JE: Immunoregulatory cell function in peripheral blood leukocytes of brain cancer patients. Neurosurgery 10:203–209, 1982.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wood, G.W., Morantz, R.A. Depressed T lymphocyte function in brain tumor patients: Monocytes as suppressor cells. J Neuro-Oncol 1, 87–94 (1983). https://doi.org/10.1007/BF00182953
Issue Date:
DOI: https://doi.org/10.1007/BF00182953